Stronger Than Life is Hard
“Dedicated to funding the development of a new life-saving treatment and supporting those affected with Beta-mannosidosis.”
What is Beta-mannosidosis?
Beta-mannosidosis (β-mannosidosis) is a rare genetic lysosomal storage disorder caused by mutations in the MANBA gene. This leads to a deficiency of the β-Mannosidase enzyme, causing toxic material buildup in cells, affecting the body and brain.
The disease varies widely in severity and can appear from infancy to adulthood. Common symptoms include intellectual disability, motor delays, speech and swallowing difficulties, vision and hearing loss, recurrent infections, seizures, scoliosis, and behavioral challenges.
There is currently no cure for this devastating disease.
Patients Affected By Beta-mannosidosis
Marco
Skylar
Kendreona
Oliver
Dean
Paul
Ground Breaking Research
At The Lost Enzyme Project, we are revolutionizing the approach to Beta-Mannosidosis, an ultra-rare genetic disorder. Partnering with leading researchers at the Kimonis Lab and JCR Pharmaceuticals, our focus is on developing a life-saving enzyme replacement therapy. We aim to deliver treatment that crosses the blood-brain barrier, targeting the brain and body effectively.
